newsfilter
← Latest News
PR Newswire·

Aspaveli® (pegcetacoplan) approved in EU as orphan drug for treatment of PNH

STOCKHOLM, Dec. 15, 2021 /PRNewswire/ -- The first targeted C3 therapy approved in the EU Approval based on results from head-to-head PEGASUS phase 3 study where Aspaveli demonstrated superiority to eculizumab in improving haemoglobin levels1 Aspa